Dhaval H. Patel
FDA investigator
Appears on 1 document from 2026, mostly at sites in New Jersey. Most often cites what are the requirements under this subpart F for written procedures? (21 CFR 111.103).
- 1
- Documents on file
- 10.0
- Observations per 483
- 2026
- First seen
- 2026
- Most recent
What they cite most
From 10 observations- 21 CFR 111.103What are the requirements under this subpart F for written procedures?1
- 21 CFR 111.455(a)What requirements apply to holding components, dietary supplements, packaging, and labels?1
- 21 CFR 111.475(b)Under this subpart M, what records must you make and keep?1
- 21 CFR 111.535(b)Under this subpart N, what records must you make and keep?1
- 21 CFR 111.553What are the requirements under this subpart O for written procedures?1
- 21 CFR 211.100(a)Written procedures; deviations1
Activity by year
2026: 1
Where
New Jersey 1
Often inspects with
Is Dhaval H. Patel coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-01-30 | 483 Safrel Pharmaceuticals LLCJan 30, 2026 · Dayton, New Jersey | Dayton, New Jersey | 10 |
About this profile
What does Dhaval H. Patel inspect?
Dhaval H. Patel appears on 1 document on file covering 1 site, mostly in New Jersey.
What do they cite most often?
21 CFR 111.103 (what are the requirements under this subpart F for written procedures?), followed by 21 CFR 111.455(a) and 21 CFR 111.475(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Dhaval H. Patel is dated Jan 30, 2026.